Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study

被引：0
|
作者：
Nicholas, M. K. [1 ,2 ,3 ,4 ]
Lucas, R. V. [1 ,2 ,3 ,4 ]
Arzbaecher, J. [1 ,2 ,3 ,4 ]
Paleologos, N. [1 ,2 ,3 ,4 ]
Krouwer, H. [1 ,2 ,3 ,4 ]
Malkin, M. [1 ,2 ,3 ,4 ]
Omar, A. [1 ,2 ,3 ,4 ]
Vick, N. A. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
[3] Waukesha Mem Hosp, Reg Canc Ctr, Waukesha, WI USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2016
引用
收藏
页数：2
相关论文
共 50 条
  • [31] IRINOTECAN (CPT11) AND TEMOZOLOMIDE (TMZ) AS ADJUVANT TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): PRELIMINARY REPORT
    Gorender, E.
    Meirelles, P. L. J.
    Epelman, S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II73 - II73
  • [32] THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Vredenburgh, James J.
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Kirkpatrick, John P.
    Herndon, James E., II
    Coan, April D.
    Bailey, Leighann
    Janney, Dorothea
    Lu, Cynthia
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2011, 13 : 89 - 90
  • [33] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [34] Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
    Reddy, Krishna
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Stuhr, Kelly
    Kavanagh, Brian D.
    Chen, Changhu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : 655 - 660
  • [35] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [36] The use of temozolomide as a radiosensitiser for the treatment of newly diagnosed glioblastoma multiforme
    Walsh, N.
    Fleet, A.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2007, 6 (02) : 103 - 110
  • [37] Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: Interim analysis of safety and tolerability
    Lai, Albert
    Filka, Emese
    McGibbon, Bruce
    Nghiemphu, Phioanh Leia
    Graham, Carrie
    Yong, William H.
    Mischel, Paul
    Liau, Linda M.
    Bergsneider, Marvin
    Pope, Whitney
    Selch, Michael
    Cloughesy, Tim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1372 - 1380
  • [38] Phase II trial of bevacizumab and temozolomide for upfront treatment of elderly patients with newly diagnosed glioblastoma.
    Nghiemphu, Phioanh Leia
    Bahng, Hye Hyun
    Lai, Albert
    Faiq, Nadia
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Cynthia Elizabeth
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Saris, G
    Beroukas, K
    Karageorgis, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2372 - 2377
  • [40] Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Coan, A. D.
    Bailey, L.
    Janney, D.
    Lu, C.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345